Texture analyses of quantitative susceptibility maps to differentiate Alzheimer's disease from cognitive normal and mild cognitive impairment

Medical Physics

Volumn 43, Issue 8, 2016, Pages 4718-4728

  Hwang, Eo Jin ^a   Kim, Hyug Gi ^b   Kim, Danbi ^a   Rhee, Hak Young ^a   Ryu, Chang Woo ^a   Liu, Tian ^c   Wang, Yi ^c   Jahng, Geon Ho ^a  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

^c NONE   (United States)

Author keywords

Alzheimer's disease; mild cognitive impairment; quantitative susceptibility mapping; structural 3D T1 weighted image; texture analysis

Indexed keywords

IMAGE ANALYSIS; IMAGE TEXTURE; NEURODEGENERATIVE DISEASES;

ALZHEIMERS DISEASE; COGNITIVE IMPAIRMENT; FIRST ORDER; MILD COGNITIVE IMPAIRMENT; QUANTITATIVE SUSCEPTIBILITY MAPPING; STRUCTURAL 3D T1-WEIGHTED IMAGE; SUSCEPTIBILITY MAPPING; SUSCEPTIBILITY MAPS; T1-WEIGHTED; TEXTURE ANALYSIS;

REGRESSION ANALYSIS;

AGED; ALZHEIMER DISEASE; ARTICLE; ARTIFACT; CLINICAL ARTICLE; ENTROPY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMAGE TEXTURE; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; QUANTITATIVE ANALYSIS; QUANTITATIVE SUSCEPTIBILITY MAPPING; RECEIVER OPERATING CHARACTERISTIC; THREE DIMENSIONAL IMAGING; WHITE MATTER; BRAIN MAPPING; COGNITION; COGNITIVE DEFECT; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ALZHEIMER DISEASE; BRAIN MAPPING; COGNITION; COGNITIVE DYSFUNCTION; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84979529654     PISSN: 00942405     EISSN: 24734209     Source Type: Journal    
DOI: 10.1118/1.4958959     Document Type: Article

References (52)

1. V. Albertini, L. Benussi, A. Paterlini, M. Glionna, A. Prestia, L. Bocchio-Chiavetto, G. Amicucci, S. Galluzzi, A. Adorni, C. Geroldi, G. Binetti, G. B. Frisoni, and R. Ghidoni, "Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia," Electrophoresis 33, 3738-3744 (2012). 10.1002/elps.201200307
2. H. Jahn, "Memory loss in Alzheimer's disease," Dialogues Clin. Neurosci. 15, 445-454 (2013).
3. D. J. Dedman, A. Treffry, J. M. Candy, G. A. Taylor, C. M. Morris, C. A. Bloxham, R. H. Perry, J. A. Edwardson, and P. M. Harrison, "Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients," Biochem. J. 287 (2), 509-514 (1992). 10.1042/bj2870509
4. C. J. Maynard, A. I. Bush, C. L. Masters, R. Cappai, and Q. X. Li, "Metals and amyloid-beta in Alzheimer's disease," Int. J. Exp. Pathol. 86, 147-159 (2005). 10.1111/j.0959-9673.2005.00434.x
5. E. M. Haacke, N. Y. Cheng, M. J. House, Q. Liu, J. Neelavalli, R. J. Ogg, A. Khan, M. Ayaz, W. Kirsch, and A. Obenaus, "Imaging iron stores in the brain using magnetic resonance imaging," Magn. Reson. Imaging 23, 1-25 (2005). 10.1016/j.mri.2004.10.001
6. J. Hardy and D. J. Selkoe, "The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics," Science 297, 353-356 (2002). 10.1126/science.1072994
7. D. Saiz-Sanchez, C. De la Rosa-Prieto, I. Ubeda-Banon, and A. Martinez-Marcos, "Interneurons, τ and amyloid- β in the piriform cortex in Alzheimer's disease," Brain Struct. Funct. 220, 2011-2025 (2014). 10.1007/s00429-014-0771-3
8. C. Carmeli, E. Fornari, M. Jalili, R. Meuli, and M. G. Knyazeva, "Structural covariance of superficial white matter in mild Alzheimer's disease compared to normal aging," Brain Behav. 4, 721-737 (2014). 10.1002/brb3.252
9. K. Ma and J. McLaurin, "α -melanocyte stimulating hormone prevents GABAergic neuronal loss and improves cognitive function in Alzheimer's disease," J. Neurosci. 34, 6736-6745 (2014). 10.1523/JNEUROSCI.5075-13.2014
10. A. Convit, M. J. de Leon, J. Golomb, A. E. George, C. Y. Tarshish, M. Bobinski, W. Tsui, S. De Santi, J. Wegiel, and H. Wisniewski, "Hippocampal atrophy in early Alzheimer's disease: Anatomic specificity and validation," Psychiatr. Q. 64, 371-387 (1993). 10.1007/BF01064929
11. D. J. Callen, S. E. Black, F. Gao, C. B. Caldwell, and J. P. Szalai, "Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD," Neurology 57, 1669-1674 (2001). 10.1212/WNL.57.9.1669
12. H. Kitagaki, E. Mori, S. Yamaji, K. Ishii, N. Hirono, S. Kobashi, and Y. Hata, "Frontotemporal dementia and Alzheimer disease: Evaluation of cortical atrophy with automated hemispheric surface display generated with MR images," Radiology 208, 431-439 (1998). 10.1148/radiology.208.2.9680572
13. A. T. Du, N. Schuff, X. P. Zhu, W. J. Jagust, B. L. Miller, B. R. Reed, J. H. Kramer, D. Mungas, K. Yaffe, H. C. Chui, and M. W. Weiner, "Atrophy rates of entorhinal cortex in AD and normal aging," Neurology 60, 481-486 (2003). 10.1212/01.WNL.0000044400.11317.EC
14. R. C. Petersen, G. E. Smith, S. C. Waring, R. J. Ivnik, E. G. Tangalos, and E. Kokmen, "Mild cognitive impairment: Clinical characterization and outcome," Arch. Neurol. 56, 303-308 (1999). 10.1001/archneur.56.3.303
15. Y. Shah, E. G. Tangalos, and R. C. Petersen, "Mild cognitive impairment. When is it a precursor to Alzheimer's disease?," Geriatrics 55 (62), 65-68 (2000).
16. J. Everett, E. Cespedes, L. R. Shelford, C. Exley, J. F. Collingwood, J. Dobson, G. van der Laan, C. A. Jenkins, E. Arenholz, and N. D. Telling, "Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β -amyloid (1-42)," J. R. Soc. Interface 11, 20140165 (2014). 10.1098/rsif.2014.0165
17. D. G. Smith, R. Cappai, and K. J. Barnham, "The redox chemistry of the Alzheimer's disease amyloid beta peptide," Biochim. Biophys. Acta 1768, 1976-1990 (2007). 10.1016/j.bbamem.2007.02.002
18. E. P. Raven, P. H. Lu, T. A. Tishler, P. Heydari, and G. Bartzokis, "Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging," J. Alzheimers Dis. 37, 127-136 (2013). 10.3233/JAD-130209
19. G. Bartzokis and T. A. Tishler, "MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease," Cell Mol. Biol. (Noisy-le-Grand) 46, 821-833 (2000).
20. D. Wang, Y. Y. Li, J. H. Luo, and Y. H. Li, "Age-related iron deposition in the basal ganglia of controls and Alzheimer disease patients quantified using susceptibility weighted imaging," Arch. Gerontol. Geriatr. 59, 439-449 (2014). 10.1016/j.archger.2014.04.002
21. -weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease," Neurobiol. Aging 36, 20-26 (2015). 10.1016/j.neurobiolaging.2014.07.006
22. M. Khalil, C. Enzinger, C. Langkammer, S. Ropele, A. Mader, A. Trentini, M. L. Vane, M. Wallner-Blazek, G. Bachmaier, J. J. Archelos, M. J. Koel-Simmelink, M. A. Blankenstein, S. Fuchs, F. Fazekas, and C. E. Teunissen, "CSF neurofilament and N -acetylaspartate related brain changes in clinically isolated syndrome," Mult. Scler. J. 19, 436-442 (2013). 10.1177/1352458512458010
23. P. F. Liu, Y. Z. Cui, J. Na, and P. Y. Gao, "Cerebral microbleeds-Prevalence, distribution and risk factors in northeast population without preceding large-area stroke," Chin. Med. J. (Engl.) 123, 286-290 (2010).
24. P. Hou, G. Liu, Y. Zhao, Z. Shi, Q. Zheng, G. Bu, H. Xu, and Y. Zhang, "The role of copper and the copper-related protein CUTA in mediating APP processing and A β generation," Neurobiol. Aging 36, 1310-1315 (2015). 10.1016/j.neurobiolaging.2014.12.005
25. A. Pal, M. Siotto, R. Prasad, and R. Squitti, "Towards a unified vision of copper involvement in Alzheimer's disease: A review connecting basic, experimental, and clinical research," J. Alzheimers Dis. 44, 343-354 (2015). 10.3233/JAD-141194
26. N. T. Watt, H. H. Griffiths, and N. M. Hooper, "Lipid rafts: Linking prion protein to zinc transport and amyloid- β toxicity in Alzheimer's disease," Front. Cell Dev. Biol. 2, 41-46 (2014). 10.3389/fcell.2014.00041
27. R. Mahlberg, S. Walther, P. Kalus, G. Bohner, S. Haedel, F. M. Reischies, K. P. Kuhl, R. Hellweg, and D. Kunz, "Pineal calcification in Alzheimer's disease: An in vivo study using computed tomography," Neurobiol. Aging 29, 203-209 (2008). 10.1016/j.neurobiolaging.2006.10.003
28. D. M. Mann, "Calcification of the basal ganglia in Down's syndrome and Alzheimer's disease," Acta Neuropathol. 76, 595-598 (1988). 10.1007/BF00689598
29. J. Wegiel, I. Kuchna, T. Wisniewski, M. J. de Leon, B. Reisberg, T. Pirttila, T. Kivimaki, and T. Lehtimaki, "Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome," Acta Neuropathol. 103, 333-343 (2002). 10.1007/s00401-001-0471-y
30. K. Imamura, M. Sawada, N. Ozaki, H. Naito, N. Iwata, R. Ishihara, T. Takeuchi, and H. Shibayama, "Activation mechanism of brain microglia in patients with diffuse neurofibrillary tangles with calcification: A comparison with Alzheimer disease," Alzheimer Dis. Assoc. Disord. 15, 45-50 (2001). 10.1097/00002093-200101000-00006
31. K. Kosaka, "Diffuse neurofibrillary tangles with calcification: A new presenile dementia," J. Neurol., Neurosurg. Psychiatry 57, 594-596 (1994). 10.1136/jnnp.57.5.594
32. J. Acosta-Cabronero, G. B. Williams, A. Cardenas-Blanco, R. J. Arnold, V. Lupson, and P. J. Nestor, "In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease," PLoS One 8, e81093 (2013). 10.1371/journal.pone.0081093
33. A. Drzezga, J. A. Becker, K. R. Van Dijk, A. Sreenivasan, T. Talukdar, C. Sullivan, A. P. Schultz, J. Sepulcre, D. Putcha, D. Greve, K. A. Johnson, and R. A. Sperling, "Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden," Brain 134, 1635-1646 (2011). 10.1093/brain/awr066
34. J. G. Csernansky, J. Hamstra, L. Wang, D. McKeel, J. L. Price, M. Gado, and J. C. Morris, "Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects," Alzheimer Dis. Assoc. Disord. 18, 190-195 (2004).
35. N. Chow, K. S. Hwang, S. Hurtz, A. E. Green, J. H. Somme, P. M. Thompson, D. A. Elashoff, C. R. Jack, M. Weiner, and L. G. Apostolova, "Comparing 3 T and 1.5 T MRI for mapping hippocampal atrophy in the Alzheimer's disease neuroimaging initiative," Am. J. Neuroradiol. 36, 653-660 (2015). 10.3174/ajnr.a4228
36. G. M. Kerbler, J. Fripp, C. C. Rowe, V. L. Villemagne, O. Salvado, S. Rose, and E. J. Coulson, "Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease," NeuroImage Clin. 7, 105-113 (2015). 10.1016/j.nicl.2014.11.015
37. F. Schweser, K. Sommer, A. Deistung, and J. R. Reichenbach, "Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain," NeuroImage 62, 2083-2100 (2012). 10.1016/j.neuroimage.2012.05.067
38. G. A. Lodygensky, J. P. Marques, R. Maddage, E. Perroud, S. V. Sizonenko, P. S. Huppi, and R. Gruetter, "In vivo assessment of myelination by phase imaging at high magnetic field," NeuroImage 59, 1979-1987 (2012). 10.1016/j.neuroimage.2011.09.057
39. K. Zhong, T. Ernst, S. Buchthal, O. Speck, L. Anderson, and L. Chang, "Phase contrast imaging in neonates," NeuroImage 55, 1068-1072 (2011). 10.1016/j.neuroimage.2010.11.086
40. B. Bilgic, A. Pfefferbaum, T. Rohlfing, E. V. Sullivan, and E. Adalsteinsson, "MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping," NeuroImage 59, 2625-2635 (2012). 10.1016/j.neuroimage.2011.08.077
41. J. Zhang, C. Yu, G. Jiang, W. Liu, and L. Tong, "3D texture analysis on MRI images of Alzheimer's disease," Brain Imaging Behav. 6, 61-69 (2012). 10.1007/s11682-011-9142-3
42. P. A. Freeborough and N. C. Fox, "MR image texture analysis applied to the diagnosis and tracking of Alzheimer's disease," IEEE Trans. Med. Imaging 17, 475-479 (1998). 10.1109/42.712137
43. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan, "Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group∗ under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease," Neurology 34, 939-944 (1984). 10.1212/WNL.34.7.939
44. G. Liu, G. Sobering, J. Duyn, and C. T. Moonen, "A functional MRI technique combining principles of echo-shifting with a train of observations (PRESTO)," Magn. Reson. Med. 30, 764-768 (1993). 10.1002/mrm.1910300617
45. T. Liu, J. Liu, L. de Rochefort, P. Spincemaille, I. Khalidov, J. R. Ledoux, and Y. Wang, "Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: Comparison with COSMOS in human brain imaging," Magn. Reson. Med. 66, 777-783 (2011). 10.1002/mrm.22816
46. T. Liu, C. Wisnieff, M. Lou, W. Chen, P. Spincemaille, and Y. Wang, "Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping," Magn. Reson. Med. 69, 467-476 (2013). 10.1002/mrm.24272
47. T. Liu, W. Xu, P. Spincemaille, A. S. Avestimehr, and Y. Wang, "Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for quantitative susceptibility mapping in MRI," IEEE Trans. Med. Imaging 31, 816-824 (2012). 10.1109/TMI.2012.2213828
48. R. Cusack and N. Papadakis, "New robust 3-D phase unwrapping algorithms: Application to magnetic field mapping and undistorting echoplanar images," NeuroImage 16, 754-764 (2002). 10.1006/nimg.2002.1092
49. T. Liu, I. Khalidov, L. de Rochefort, P. Spincemaille, J. Liu, A. J. Tsiouris, and Y. Wang, "A novel background field removal method for MRI using projection onto dipole fields (PDF)," NMR Biomed. 24, 1129-1136 (2011). 10.1002/nbm.1670
50. J. Liu, T. Liu, L. de Rochefort, J. Ledoux, I. Khalidov, W. Chen, A. J. Tsiouris, C. Wisnieff, P. Spincemaille, M. R. Prince, and Y. Wang, "Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map," NeuroImage 59, 2560-2568 (2012). 10.1016/j.neuroimage.2011.08.082
51. J. Ashburner and K. J. Friston, "Unified segmentation," NeuroImage 26, 839-851 (2005). 10.1016/j.neuroimage.2005.02.018
52. --weighted magnetic resonance imaging: Application in Alzheimer's disease patients," NeuroImage 51, 1082-1088 (2010). 10.1016/j.neuroimage.2010.03.048